Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Corporativo FraguaB de CVMEX:FRAGUAB +3.44%84 ROA % is 9.07% as of Dec. 2024, which is 37% above its 10-year median of 6.63. GuruFocus rates MEX:FRAGUAB with a GF Score™ of 84/100 and a GF Value™ of MXN697.68 (Significantly Undervalued). Among 679 Healthcare Providers & Services companies, Corporativo FraguaB de CV ranks better than 83.06% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Corporativo FraguaB de CV's annualizedNet Income for the quarter that ended in Dec. 2024 was MXN4,902 Mil.
Corporativo FraguaB de CV's average Total Assets over the quarter that ended in Dec. 2024 was MXN54,076 Mil. Therefore, Corporativo FraguaB de CV's annualized ROA % for the quarter that ended in Dec. 2024 was 9.07%.
The historical rank and industry rank for Corporativo FraguaB de CV's ROA % or its related term are showing as below:
MEX:FRAGUAB'
s ROA % Range Over the Past 10 Years
Min: 6.12 Med: 6.63 Max: 9.56
Current: 9.07
During the past 13 years, Corporativo FraguaB de CV's highest ROA % was 9.56%. The lowest was 6.12%. And the median was 6.63%.
MEX:FRAGUAB's ROA % is ranked better than 83.06% of 679
companies
in the Healthcare Providers & Services industry
Industry Median: 1.85
vs MEX:FRAGUAB: 9.07
Corporativo FraguaB de CV (MEX:FRAGUAB) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is one times the annual (Dec. 2024) net income data. The Revenue data used here is one times the annual (Dec. 2024) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Corporativo FraguaB de CV ROA % Competitor Comparison
For the Pharmaceutical Retailers subindustry, Corporativo FraguaB de CV's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Corporativo FraguaB de CV ROA % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Corporativo FraguaB de CV's ROA % distribution charts can be found below:
* The bar in red indicates where Corporativo FraguaB de CV's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is one times the annual (Dec. 2024) net income data.
ROA % is displayed in the 30-year financial page.
Corporativo FraguaB de CV (MEX:FRAGUAB) has a ROA % of 9.07% as of Dec. 2024. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Corporativo FraguaB de CV and its competitors. This is 37% above median its historical median of 6.63. Over the past decade, Corporativo FraguaB de CV's ROA % has ranged from 6.12 to 9.56. According to the industry distribution chart, Corporativo FraguaB de CV ranks #115 out of 679 companies in the Healthcare Providers & Services industry, placing it in the top 16.9%.
Is Corporativo FraguaB de CV's ROA % too high?
Corporativo FraguaB de CV's current ROA % of 9.07% is 37% above median its 10-year median of 6.63. Over the past 10 years, this metric has ranged from a low of 6.12 to a high of 9.56. The Healthcare Providers & Services industry median ROA % is 1.85. Corporativo FraguaB de CV's value of 9.07% is 390.3% above this industry median. Based on the distribution chart, Corporativo FraguaB de CV ranks #115 out of 679 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Corporativo FraguaB de CV has a GF Score™ of 84/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Corporativo FraguaB de CV's ROA % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Corporativo FraguaB de CV ranks #115 out of 679 companies for ROA %. This places Corporativo FraguaB de CV in the top 17% of its industry — outperforming the majority of peers. The industry median ROA % is 1.85. Corporativo FraguaB de CV's value of 9.07% is 390.3% above this benchmark. Historically, Corporativo FraguaB de CV's own ROA % has ranged from 6.12 to 9.56 over the past decade. While the company's 10-year median is 6.63 vs. the industry median of 1.85, Corporativo FraguaB de CV has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Healthcare Providers & Services company?
The median ROA % among Healthcare Providers & Services companies is 1.85, based on 679 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Corporativo FraguaB de CV's current ROA % of 9.07% is 390.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Corporativo FraguaB de CV and its competitors. For the Healthcare Providers & Services industry, the median ROA % is 1.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Corporativo FraguaB de CV's current ROA % is 9.07%, which is 37% above median its own 10-year median of 6.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Corporativo FraguaB de CV stock overvalued right now?
Based on GuruFocus' analysis, Corporativo FraguaB de CV (MEX:FRAGUAB) is currently considered Significantly Undervalued. The stock's GF Value™ is MXN697.68, compared to a current price of MXN479.99 — trading 31.2% below its estimated fair value. The current ROA % is 9.07%, which is 37% above median its 10-year median of 6.63 and 390.3% above the Healthcare Providers & Services industry median of 1.85. Corporativo FraguaB de CV's overall GF Score™ is 84/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Corporativo FraguaB de CV (MEX:FRAGUAB), the current ROA % is 9.07% as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Corporativo FraguaB de CV (MEX:FRAGUAB) Overvalued in 2026?
Based on GuruFocus' analysis, Corporativo FraguaB de CV stock appears to be undervalued.
The current stock price of MXN479.99 is trading 31.2% below its estimated GF Value™ of MXN697.68.
GuruFocus considers Corporativo FraguaB de CV to be Significantly Undervalued.
Key valuation signals for MEX:FRAGUAB:
ROA %: 9.07% (37% above median its 10-year median of 6.63)
GF Value™: MXN697.68 vs. price of MXN479.99 (31.2% below fair value)
Industry Position: 390.3% above the Healthcare Providers & Services median (#115 of 679)
No single metric tells the full story. See the MEX:FRAGUAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Corporativo Fragua SAB de CV is engaged in the drug retail sector in Mexico. The company operates a network of pharmacies under the SuperFarmacia brand name, focusing on selling medicines, medical devices, and a variety of other products, including grocery items, exercise machines, perfumes, housewares, electronics, personal care products, toys, and photographic equipment.
84GF Score
Get the complete analysis for MEX:FRAGUAB
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:FRAGUAB has been successfully added to your 
